|
Originally published In Press as doi:10.1074/jbc.C100642200 on December 11, 2001
J. Biol. Chem., Vol. 277, Issue 5, 3419-3423, February 1, 2002
A Novel Long N-terminal Isoform of Human L-type Ca2+
Channel Is Up-regulated by Protein Kinase C*
Yakov
Blumenstein,
Nataly
Kanevsky,
Gideon
Sahar ,
Rachel
Barzilai,
Tatiana
Ivanina, and
Nathan
Dascal§
From the Department of Physiology and Pharmacology, Sackler School
of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel and
Rabin Medical Center, Petach Tikva 49100, Israel
Received for publication, November 7, 2001, and in revised form, December 10, 2001
 |
ABSTRACT |
Human L-type voltage-dependent
Ca2+ channels ( 1C, or
Cav1.2) are up-regulated by protein kinase C (PKC) in
native tissues, but in heterologous systems this modulation is absent.
In rat and rabbit, 1C has two N-terminal (NT) isoforms,
long and short, with variable initial segments of 46 and 16 amino
acids, respectively. The initial 46 amino acids of the long-NT
1C are crucial for PKC regulation. However, only a
short-NT human 1C is known. We assumed that a long-NT
isoform of human 1C may exist. By homology screening of
human genomic DNA, we identified a stretch (termed exon 1a) highly
homologous to rabbit long-NT, separated from the next known exon of
1C (exon 1b, which encodes the alternative, short-NT) by
an ~80 kb-long intron. The predicted 46-amino acid protein sequence
is highly homologous to rabbit long-NT. Reverse transcriptase PCR
showed the presence of exon 1a transcript in human cardiac RNA.
Expression of human long-NT 1C in Xenopus oocytes produced Ca2+ channel enhanced by a PKC activator,
whereas the short-NT 1C was inhibited. The long-NT
isoform may be the Ca2+ channel enhanced by PKC-activating
transmitters in human tissues.
 |
INTRODUCTION |
Voltage-dependent L-type Ca2+ channels are
crucial for cardiac and smooth muscle contraction and hormone
secretion, and they regulate gene expression in the brain (1-3). Their
function is highly regulated by hormones and neurotransmitters, largely
via activation of protein kinases (3, 4). Regulation by
PKC1 is believed to be of
substantial physiological importance, mediating all or part of the
effects of several hormones and intracellular messengers (4). PKC
enhances L-type Ca2+ currents in diverse human tissues and
cell lines: heart, neuroblastoma, T-cells, and endocrine cells (5-10).
Dual modulation by PKC is often observed with activation followed by,
or concomitant with, inhibition (5, 10). Similar enhancement by PKC,
sometimes followed by inhibition, has been described in other mammals
(11, 12) and was reproduced in Xenopus oocytes expressing
the cloned rabbit cardiac L-type Ca2+ channels (13, 14).
However, expression of human L-type channels, encoded by all cDNA
cloned to date, yielded Ca2+ channels that were only
inhibited by PKC; the enhancement could not be reconstituted (15). The
reason for the inability to reproduce the PKC modulation of human
L-type channels remained unknown.
The main, pore-forming subunit of cardiac/smooth muscle L-type channel
( 1C or Cav1.2), also present in the brain,
is the product of the 1C gene, CACNA1C
(16). Several splice variants of CACNA1C are known (17, 18).
The resulting isoforms of human 1C protein show
differential distribution in human tissues, and in failing
versus normal myocardium. They play important roles in Ca2+-dependent inactivation, oxygen sensing,
and drug sensitivity (18-22). However, the genomic structure of the
beginning of N-terminal region of human 1C is not
entirely clear. In the two best studied mammalian species, rat and
rabbit, two N-terminal isoforms of 1C cDNA are
known, which most probably represent variable splicing products of the
same gene (23). These splice variants encode long- and short-NT
1C proteins, with variable initial segments of 46 and 16 aa, respectively (23-26) (the total length of the cytosolic part of
the NT region of 1C is ~154 aa in the long-NT 1C). Traditionally, the short-NT isoform is called
"neuronal" in rat and "smooth muscle" in rabbit, whereas the
long-NT isoform is considered "cardiac" in rabbit. However, in rat,
1C protein containing the long-NT is found in both heart
and brain (27). The known human 1C is highly homologous
to short-NT isoforms of rat and rabbit; the long-NT isoforms of rat and
rabbit are also highly homologous to each other. Because the human
L-type channel is up-regulated by PKC, and because the initial 20 aa of
the long-NT isoform are crucial for this regulation in rabbit 1C (27, 28), we reasoned that a long-NT isoform of human 1C should also exist.
Here we demonstrate the presence of an exon encoding the initial 46-aa
long-NT segment in the human genomic DNA. The existence of
1C RNA containing this segment was confirmed by RT-PCR
gel analysis and DNA sequencing of the RT-PCR product. Using the RT-PCR products, we have demonstrated that cDNA coding for a full-length long-NT 1C isoform expressed in Xenopus
oocytes produces a Ca2+ channel that is enhanced by a PKC
activator. The identification of the long-NT isoform of human
1C will enable the study of the molecular mechanisms of
PKC modulation, which has previously been hampered by the inability to
reconstitute this modulation in expression systems.
 |
EXPERIMENTAL PROCEDURES |
Tissues and Oocyte Culture--
All experiments with human and
animal tissues were approved by the Tel Aviv University Helsinki
Committee and the Sackler School of Medicine Animal Use Committee,
respectively. Rat atria and ventricles were obtained from 19-day-old
Wistar rats after decapitation performed under ether anesthesia.
Xenopus frogs were maintained and operated
on, and oocytes were prepared as described (29). Each oocyte was
injected with 2.5 ng of RNAs of 1C,
2/ , and 2A subunits and incubated for 3-4
days at 20-22 °C in NDE96 solution (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 2.5 mM sodium pyruvate,
50 µg/ml gentamycin, 5 mM HEPES, pH 7.5).
RT-PCR Analysis--
5 µg of total human cardiac RNA purchased
from Ambion, Inc. (catalog no. 7966, lot 110P43B) was
reverse-transcribed with SuperScript II reverse transcriptase
(Invitrogen) with primer 3 (see text below and Fig.
2A). Each PCR reaction (50 µl) contained 2.4 µl of the
product of RT reaction, 1 µl of 10 mM dNTPs, 20-50 pmol of primers, 5 µl of 10× PCR buffer, 2 µl of Mg2+ (2 mM), and 0.7 µl of Taq DNA polymerase
(Promega). PCR was performed under the following conditions: 95 °C
for 1 min, 49 °C for 1 min, and 72 °C for 2 min, repeated 35 times. The final elongation was performed at 72 °C for 5 min. The
PCR products were analyzed on a 1% agarose gel.
The primers used for RT and PCR were: No. 1, CTTCGAGCCTTTGTTCAG
(nt 4-21 from A in ATG of exon 1a); No. 2, TCAATGAGAATACGAGGA (nt
5-22 in exon 1b; numbering from ATG of the short-NT isoform 1C,77 (17)); No. 3, ATTGGTGGCGTTGGAATC (nt 468-451;
numbering from ATG of exon 1b); No. 4, TAAAGTGAAATAAAGAGT (within the
proposed intron between exon 1a and exon 1b; nt 95529-95546 in contig
38105732; +149 nt from A in ATG of exon 1a); No. 5, ATACCACTACTGAATATA (within the same intron, nt 95896-95913 in contig
3810573; +516 nt from A in ATG in exon 1a); No. 6, AACTGAGAAAGTGGCTTT
(2369 nt upstream from A in ATG of exon 1a; nt 93010-93027 in contig 3810573); No. 7, GCAGGTTAGTGTAGGAAT (1339 nt upstream from A in ATG of
Exon 1a; nt 94040-94057 in contig 3810573); No. 9, CCATTCGACAATGCTGAT (nt 369-352 in exon 2; numbering from ATG of exon 1b of
1C,77); No. 10, GATACGATACGGCCATGT (within the proposed
5'-UTR of exon 1a, 147 nt upstream from A in ATG of exon 1a; nt
95232-95239 in contig 3810573).
DNA Constructs--
cDNAs of 2/ and 2A
were as described (30). cDNA of human short-NT isoform
1C,77 (Ref. 31; GenBankTM accession No.
Z34815) was obtained from Dr. R. Zuhlke and subcloned into
pGEM-HJ vector (which contains 5'- and 3'-UTRs of Xenopus
-globin flanking the polylinker). In the resulting construct, termed
1C,77S, the 5'-UTR of -globin is followed by a
BamHI restriction site and then immediately by the initial ATG. The coding sequence of 1C,77 is followed by the
3'-UTR of -globin and then by a SalI site. The DNA of the
long-NT, termed 1C,77L, was constructed as follows. The
human heart cDNA obtained in the RT reaction described above was
subjected to PCR with the reverse primer No. 3 (see above) and a
forward primer ATTCGCGGATCCATGCTTCGAGCCTTTGTT that overlaps the first
18 nt of the coding part of exon 1a (starting with ATG) and also
creates a BamHI restriction site preceding ATG. The PCR
product was digested with BamHI and MfeI (a
unique MfeI site is present in exon 3 upstream of primer No.
3) and inserted between these restriction sites into
BamHI/MfeI-digested 1C,77S in
place of the original DNA segment flanked by these sites. The 5'
portion of the resulting DNA was sequenced. The sequence of the
BamHI-MfeI segment obtained by this RT-PCR
subcloning procedure was 100% identical to that predicted for
the long-NT splice variant (based on the DNA sequence of chromosome
12), in which exon 1a is followed by exons 2 and 3 (see Fig.
1C). RNA was synthesized as described (29).
Electrophysiology--
Whole cell currents were recorded using
the Gene Clamp 500 amplifier (Axon Instruments, Foster City, CA) using
the two-electrode voltage clamp technique, as described (30), in a
solution containing 40 mM Ba(OH)2, 50 mM NaOH, 2 mM KOH, and 5 mM HEPES,
titrated to pH 7.5 with methanesulfonic acid. PMA and
bisindolylmaleimide (BIS) were purchased from Sigma. Oocytes were
treated with BIS essentially as described (32). In brief, the oocyte
was injected with 30 nl of a water solution of BIS at 150 µM and, in addition, incubated in 5 µM BIS
2-4 h before recording. Stimulation, data acquisition, and analysis
were performed using pCLAMP software (Axon Instruments).
 |
RESULTS AND DISCUSSION |
The initial exon of the previously described (17) human
1C clone, which we now designate exon 1b, contains a
5'-UTR and encodes the first 16 aa of the short-NT 1C
protein. To find out whether DNA sequences that encode an alternative,
long-NT isoform of human 1C exist, we performed a
standard BLAST search of human genomic
DNA,2 using as our query the
cDNA sequence encoding the first 46 aa of the rabbit cardiac
long-NT clone (24). The initial search showed the presence of a highly
homologous sequence in the contig 38105733 from human
chromosome 12, locus p13.3 (Fig.
1A; the region of the initial
search is highlighted by bold letters). This is within the
region where the gene of 1C, CACNA1C, is
located. Significantly, the sequence upstream from this segment showed
significant homology to the 5'-UTR of the rabbit 1C
(Fig. 1A), supporting the possibility that it may be part of
an initial exon of a human L-type channel. We have designated this
tentative exon as 1a. Within the presumably protein-coding part of exon
1a, a 45-base-long DNA segment, starting at base 16 (from the initial
ATG) also shares 40% homology with the protein-coding part of exon 1b
(Fig. 1A).

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 1.
The newly identified exon 1a and the proposed
DNA and protein structure of two NT isoforms of human
1C. A, nucleotide
homology between rabbit heart (RH) long-NT cDNA, the
homologous part of human chromosome 12 corresponding to the proposed
exon 1a (ex1a), and the coding sequence of the known exon 1b
(ex1b). Full homology is indicated by asterisks. Bold
letters show the protein-coding sequence of long-NT isoforms.
B, the location of exons and introns according to the draft
map of chromosome 12 available at the NCBI site. C, the DNA
sequences corresponding to proposed alternative splice variants
encoding long- and short-NT isoforms of 1C. The
middle section shows the 5' part of the CACNA1C gene,
with boxes representing exons and angled lines
representing introns. D, comparison of the protein sequences
of rabbit cardiac 1C and the two proposed isoforms of
the human 1C. Asterisks show fully conserved
aa; bold letters highlight the PKC phosphorylation sites
responsible for the inhibitory effect of PMA in rabbit
1C (35); the underlined residues are
those that differ in rabbit and human long-NT 1C.
|
|
The availability of the draft sequence of the human chromosome 12 on
the NCBI Human Genome site allowed us to map the location of the
putative exon 1a relative to the known exons of the human 1C gene (Fig. 1B). Exon 1a precedes exon 1b
and is separated from the latter by ~80 kb. We assume that this is a
large intron. Two other large introns are found, according to the draft
map of the chromosome, between exon 1b and exon 2 (~60 kb) and
between exons 3 and 4 (~330 kb). These large introns have not been
fully sequenced previously; introns of >5 and 2.4 kb have been
reported (17). The location of exon 1a supports the possibility that it
constitutes the first alternative exon of the CACNA1C gene. The screening procedure also confirmed the presence and the correct spatial location on chromosome 12 of all the of constant and
alternative exons described by Soldatov in 1994 (17) (Fig.
1B show 10 of the 50 exons, excluding exon 1a).
Our working hypothesis was that exons 1a and 1b are alternative initial
exons of the human CACNA1C gene (Fig. 1C). Exons
2 and 3 are probably constant (17), as supported by the conservation of
the corresponding protein sequences in known long- and short-NT 1C isoforms in human, rat, rabbit, and mouse (Fig.
1D and Refs. 23, 27, and 28). The protein sequences of N
termini of the proposed human 1C short- and long-NT
isoforms are shown in Fig. 1D and are compared with the
rabbit long-NT 1C. The segment corresponding to exon 2 starts after aa 46 in the long-NT isoform and after aa 16 in the
short-NT isoform. The protein segment encoded by exon 3 starts at aa
155, exactly at the proposed junction between the cytosolic NT and the
first transmembrane segment of the channel, IS1 (24).
To further substantiate our working hypothesis, we performed RT-PCR on
total human cardiac RNA. cDNA was obtained by reverse transcription
using primer No. 3 (Fig. 2A),
which corresponds to the 3' end of exon 3. The analytical PCR was done
with primers corresponding to segments of chromosome 12 DNA, as
published at the NCBI Human Genome site, within the putative exons and
introns of the 5' region of CACNA1C. The location of
primers is shown in Fig. 2A. Clear bands were detected for
all DNAs that contained exon 1a (Fig. 2B): protein-coding
sequences of [exon 1a + exon 2 + exon 3] (lane 1) and
[exon 1a + exon 2] (lane 3); [exon 1a including 5'UTR + exon 2] (lane 5). The sizes of the DNAs corresponded to
those expected for an RNA transcript that contains exons 1a, 2, and 3 without 1b. Control reactions, with primers within the presumed intron regions (lanes 6 and 7) and
~1.4-2.4 kb upstream from the beginning of exon 1a (lane
8) did not yield signals. Another cDNA segment that included
protein-coding sequences of exon 1a, 2, and (part of) 3 was obtained
for subcloning purposes (see "Experimental Procedures") and
sequenced. The size and the DNA sequence of this RT-PCR product were
exactly as expected for [exon 1a + exon 2 + exon 3 up to
MfeI site] without exon 1b and encoded the first
46 aa of the proposed long-NT isoform of 1C followed by
protein sequences highly conserved in all known isoforms of
1C. These results strongly support the presence in human
cardiac tissue of an RNA species encoding the proposed long-NT isoform shown in Fig. 1, C and D.

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 2.
RT-PCR supports the existence of human
long-NT isoform. A, the location of primers used for
RT-PCR. B, RT-PCR products obtained with the primer pairs
shown below the lanes. Primers were added to the PCR
reactions at 50 pM. The sizes of DNAs expected from the
hypothesis of Fig. 1A were, by lanes (in nt):
1, 547; 2, 463; 3, 449; 4,
365; 5, 591; 6-8, no PCR products were expected.
C, RT-PCR with 20 pM primers, showing
lanes 3 and 4 as in panel B.
|
|
A band corresponding to the DNA of exons [1b + 2 + 3] was also
obtained; the size was exactly as expected for a short-NT isoform, without 1a (Fig. 2B, lane 2). Under
standard conditions the band corresponding to [exon 1b +exon 2] was
not detected (Fig. 2B, lane 4), but varying the
conditions of PCR revealed this band, although it still remained
relatively weak (Fig. 2C). Thus, RNA of the previously
described short-NT isoform is also present in human cardiac tissue.
Previously, the existence of a long-NT 1C protein in rat
has been demonstrated by Western blot with a polyclonal antibody directed against the unique initial 46 aa of the rabbit long-NT isoform
(27). The same antibody detected a >220 kDa protein (presumably the
L-type Ca2+ channel) in a human colon cancer cell line
(33). These results corroborate the presence of the long-NT
1C protein in human tissues. Taken together, our data
and those of Ref. 33 support the notion that human cardiac (and
probably other) tissues contain two N-terminal isoforms of
1C protein, a long-NT and a short-NT one, which are products of alternatively spliced RNA transcripts of the 5'-terminal region of the CACNA1C gene (as shown in Fig. 1, C
and D).
According to our initial hypothesis, the long-NT 1C
should be up-regulated by the activation of PKC. To test this
prediction, we constructed a cDNA encoding a long-NT
1C on the basis of a human short-NT 1C
DNA, 1C,77 (19). Both cDNAs were subcloned into the
pGEM-HJ vector and verified by DNA sequencing (see "Experimental Procedures"). The long-NT clone was designated 1C,77L
and the short-NT clone 1C,77S. The corresponding RNAs
were synthesized in vitro and injected into
Xenopus oocytes with RNA of the 2/ subunit
with or without RNA of the 2A subunit (30). The
voltage-dependent Ba2+ currents
(IBa) via the expressed 1C,77L and
1C,77S Ca2+ channels ranged from 100 to 800 nA without 2A and from 1500 to 7000 nA with 2A. The kinetics of
IBa of 1C,77L and 1C,77S (e.g. Fig. 3C) were
very similar to each other and to those directed by rabbit cardiac
1C. The other parameters also resembled those previously
reported for L-type Ca2+ channels of various species. For
instance, as described previously for the rabbit 1C (30,
34), coexpression of the 2A subunit increased the current amplitude
9.5 ± 0.4-fold in 1C,77L and 9.3 ± 0.6-fold
in 1C,77S, and shifted the voltage dependence of
activation to more negative potentials, as shown by normalized current-voltage curves (Fig. 3A). Peak IBa was
similar in the long-NT and short-NT isoforms; the small difference was
statistically significant (Fig. 3B), but at present we do
not know whether this reflects differences in protein expression or in
the gating properties of the two isoforms.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 3.
PKC up-regulates the long-NT isoform of
human 1C. In all cases, data
are shown as the mean ± S.E., and the numbers of cells tested are
indicated above the bars. **, indicates
p < 0.01 (by t test). A,
current-voltage relations of 1C,77S and
1C,77L expressed with 2/ with or
without 2A. B, relative amplitudes of peak
IBa of 1C,77S and 1C,77L
(with 2/ + 2A) measured at +20 mV in four oocyte
batches. In each oocyte, IBa was normalized to the average
current amplitude of the 1C,77L group of the same batch.
C, the effect of 10 nM PMA in a representative
oocyte expressing 1C,77L + 2/ + 2A.
IBa was measured by 300-ms steps to 20 mV from a holding
potential of 80 mV delivered every 30 s. D, the time
course of PMA effect in two oocytes of the same donor expressing the
two 1C isoforms (with 2/ + 2A). PMA
was applied at time point zero after stabilization of the leak and
Ba2+ currents (see Ref. 13 for details of PMA use).
E, summary of experiments done with PMA.
|
|
The prediction that the long-NT human 1C should be
enhanced by PKC has been fully confirmed. The main effect of the
phorbol ester -PMA (a PKC activator) was to increase the
Ba2+ current of 1C,77L coexpressed with
2/ with or without 2A (Fig. 3, C-E).
As in the rabbit 1C channel (13), the increase reached a
maximum within 5-8 min and was followed by a decrease, sometimes below
the basal current level (Fig. 3D). In contrast, the short-NT
1C,77S channels were inhibited by PMA (Fig.
3D), in line with the previous report (15). On average, PMA
increased the current via the long-NT channels by 22.7 ± 4.4% in
the absence of 2A subunit and by 21.2 ± 4.2% in its presence
(Fig. 3E). The PMA-induced increase in IBa was
fully blocked by the specific PKC inhibitor, bisindolylmaleimide (Fig.
3E; bar marked BIS), supporting the notion that
the enhancement of IBa by PMA was indeed mediated by PKC.
Thus, in general, the modulation of the human long-NT isoform by PKC is
similar to that of the rabbit cardiac channel. With rabbit cardiac
L-type channel, coexpression of 2A substantially weakens the
enhancement of the current by PMA (13), whereas in the human channel
this action of 2A is less pronounced. It would be of interest to see
whether this is due to one of the few differences in the primary amino
acid composition of the 46-aa-long initial NT segment in human and
rabbit (Fig. 1D, underlined amino acids).
In a different expression system (human embryonic kidney cell line
tsA-201), only inhibition of the rabbit long-NT 1C by PMA has been observed (35). The inhibition crucially depended on the
presence of each of the two threonines, Thr27 and
Thr31 (shown in bold in Fig. 1D), in
which phosphorylation by PKC was proposed to underlie this modulation.
It has been proposed that the lack of PKC-induced enhancement in
tsA-201 cells may result from the absence of a specific PKC isozyme
(35). At present, we do not know whether the phosphorylation of
Thr31 (Thr27 is absent in the long-NT human
1C; Fig. 1D) plays a role in any of the PKC
effects observed in Xenopus oocytes. We suspect that the
mechanism of PMA-induced inhibition of 1C in oocytes is
different from that observed in tsA-201 cells, because a short-NT isoform of rat 1C was not sensitive to PMA in this
system (35), whereas the homologous short-NT human 1C is
inhibited by PKC in Xenopus oocytes (Ref. 15 and Fig. 3).
Furthermore, the decrease of IBa is still observed in the
presence of BIS (Fig. 3E), whereas in tsA-201 cells PKC
inhibitors blocked the effect of PMA (35). The PMA-induced inhibition
of human L-type Ca2+ channels observed in
Xenopus oocytes requires further study.
Because the most widely observed effect of PKC activators on human
L-type Ca2+ channels is an enhancement of the current
(sometimes accompanied by an inhibition (5-10)), and because this
regulation is reproduced with the long-NT 1C in
Xenopus oocytes, we propose that the long-NT 1C is the isoform that underlies the PKC-induced
enhancement. The homologous long-NT rabbit 1C isoform
behaves in the same way when expressed in oocytes (13, 28), probably by
means of an identical molecular mechanism as in human
1C. The four aa following the initial methionine in
rabbit long-NT 1C, LRAL, are necessary for PKC-induced
enhancement. Because this protein segment contains no putative
phosphorylation sites, we have proposed that PKC phosphorylation occurs
elsewhere in 1C or in an auxiliary protein, whereas the
first five aa play a role in PKC anchoring or in channel gating (27).
The short-NT isoform lacks these four amino acids; its initial 15-aa
segment (following the first methionine) carries a partial homology to
amino acids 6-20 of the long-NT isoform (Fig. 1D). In
rabbit long-NT 1C, the first 20 aa play the role of the
inhibitory gating element, which reduces the open probability of the
L-type channel4 (27, 28). It
would be of great interest to see whether this is also the case in
human long-NT 1C. We hope that the discovery of the
long-NT isoform of human 1C and the demonstration of its modulation by PKC, as described in this report, will provide the basis
and the incentive for future studies of PKC targets ( 1C or an auxiliary protein?) and of the interaction between the
phosphorylated and gating parts of 1C in PKC modulation.
 |
ACKNOWLEDGEMENTS |
We thank R. Zuhlke and N. Soldatov, who
kindly provided the cDNA of 1C,77; G. Ast for
advice; and J. Hirsch for critical reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported by Israel Basic Research Grant
47/00-16.0.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed. Tel.: 972-3-6405742;
Fax: 972-3-6409113; E-mail: dascaln@post.tau.ac.il.
Published, JBC Papers in Press, December 11, 2001, DOI 10.1074/jbc.C100642200
2
Found on the Web at
ncbi.nlm.nih.gov/BLAST.
3
NCBI accession number AC005342.
4
N. Kanevsky and N. Dascal, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
PKC, protein kinase
C;
aa, amino acid;
NT, N-terminal;
nt, nucleotide;
UTR, untranslated
region;
RT, reverse transcriptase;
PMA, 4 -phorbol 12-myristate
13-acetate;
BIS, bisindolylmaleimide;
contig, group of overlapping
clones.
 |
REFERENCES |
| 1.
|
Reuter, H.
(1983)
Nature
301,
569-574[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Finkbeiner, S.,
and Greenberg, M. E.
(1998)
J. Neurobiol.
37,
171-189[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Catterall, W. A.
(2000)
Annu. Rev. Cell Dev. Biol.
16,
521-555[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Kamp, T. J.,
and Hell, J. W.
(2000)
Circ. Res.
87,
1095-1102[Abstract/Free Full Text]
|
| 5.
|
Schuhmann, K.,
and Groschner, K.
(1994)
FEBS Lett.
341,
208-212[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Reeve, H. L.,
Vaughan, P. F.,
and Peers, C.
(1995)
Pflugers Arch. Eur. J. Physiol
429,
729-737[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Love, J. A.,
Richards, N. W.,
Owyang, C.,
and Dawson, D. C.
(1998)
Am. J. Physiol.
274,
G397-G405[Abstract/Free Full Text]
|
| 8.
|
Hernandez, M. E.,
del Mar Hernandez, M.,
Diaz-Munoz, M.,
Clapp, C.,
and de la Escalera, G. M.
(1999)
Neuroendocrinology
70,
31-42[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Savignac, M.,
Badou, A.,
Moreau, M.,
Leclerc, C.,
Guery, J. C.,
Paulet, P.,
Druet, P.,
Ragab-Thomas, J.,
and Pelletier, L.
(2001)
FASEB J.
15,
1577-1579[Free Full Text]
|
| 10.
|
Boixel, C.,
Tessier, S.,
Pansard, Y.,
Lang-Lazdunski, L.,
Mercadier, J. J.,
and Hatem, S. N.
(2000)
Am. J. Physiol.
278,
H670-H676
|
| 11.
|
Lacerda, A. E.,
Rampe, D.,
and Brown, A. M.
(1988)
Nature
335,
249-251[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Tseng, G. N.,
and Boyden, P. A.
(1991)
Am. J. Physiol.
261,
H364-H379[Abstract/Free Full Text]
|
| 13.
|
Singer-Lahat, D.,
Gershon, E.,
Lotan, I.,
Hullin, R.,
Biel, M.,
Flockerzi, V.,
Hofmann, F.,
and Dascal, N.
(1992)
FEBS Lett.
306,
113-118[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Bourinet, E.,
Fournier, F.,
Lory, P.,
Charnet, P.,
and Nargeot, J.
(1992)
Pflugers Arch. Eur. J. Physiol
421,
247-255[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Bouron, A.,
Soldatov, N. M.,
and Reuter, H.
(1995)
FEBS Lett.
377,
159-162[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Ertel, E. A.,
Campbell, K. P.,
Harpold, M. M.,
Hofmann, F.,
Mori, Y.,
Perez-Reyes, E.,
Schwartz, A.,
Snutch, T. P.,
Tanabe, T.,
Birnbaumer, L.,
Tsien, R. W.,
and Catterall, W. A.
(2000)
Neuron
25,
533-535[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Soldatov, N. M.
(1994)
Genomics
22,
77-87[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Klockner, U.,
Mikala, G.,
Eisfeld, J.,
Iles, D. E.,
Strobeck, M.,
Mershon, J. L.,
Schwartz, A.,
and Varadi, G.
(1997)
Am. J. Physiol.
272,
H1372-H1381[Abstract/Free Full Text]
|
| 19.
|
Soldatov, N. M.,
Zuhlke, R. D.,
Bouron, A.,
and Reuter, H.
(1997)
J. Biol. Chem.
272,
3560-3566[Abstract/Free Full Text]
|
| 20.
|
Zuhlke, R. D.,
Bouron, A.,
Soldatov, N. M.,
and Reuter, H.
(1998)
FEBS Lett.
427,
220-224[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Yang, Y.,
Chen, X.,
Margulies, K.,
Jeevanandam, V.,
Pollack, P.,
Bailey, B. A.,
and Houser, S. R.
(2000)
J. Mol. Cell. Cardiol.
32,
973-984[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Fearon, I. M.,
Varadi, G.,
Koch, S.,
Isaacsohn, I.,
Ball, S. G.,
and Peers, C.
(2000)
Circ. Res.
87,
537-539[Abstract/Free Full Text]
|
| 23.
|
Snutch, T. P.,
Tomlinson, W. J.,
Leonard, J. P.,
and Gilbert, M. M.
(1991)
Neuron
7,
45-57[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Mikami, A.,
Imoto, K.,
Tanabe, T.,
Niidome, T.,
Mori, Y.,
Takeshima, H.,
Narumiya, S.,
and Numa, S.
(1989)
Nature
340,
230-233[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Biel, M.,
Ruth, P.,
Bosse, E.,
Hullin, R.,
Stuhmer, W.,
Flockerzi, V.,
and Hofmann, F.
(1990)
FEBS Lett.
269,
409-412[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Koch, W. J.,
Ellinor, P. T.,
and Schwartz, A.
(1990)
J. Biol. Chem.
265,
17786-17791[Abstract/Free Full Text]
|
| 27.
|
Shistik, E.,
Keren-Raifman, T.,
Idelson, G. H.,
Dascal, N.,
and Ivanina, T.
(1999)
J. Biol. Chem.
274,
31145-31149[Abstract/Free Full Text]
|
| 28.
|
Shistik, E.,
Ivanina, T.,
Blumenstein, Y.,
and Dascal, N.
(1998)
J. Biol. Chem.
273,
17901-17909[Abstract/Free Full Text]
|
| 29.
|
Dascal, N.,
and Lotan, I.
(1992)
in
Protocols in Molecular Neurobiology
(Longstaff, A.
, and Revest, P., eds), Vol. 13
, pp. 205-225, Humana Press, Totowa, NJ
|
| 30.
|
Singer, D.,
Biel, M.,
Lotan, I.,
Flockerzi, V.,
Hofmann, F.,
and Dascal, N.
(1991)
Science
253,
1553-1557[Abstract/Free Full Text]
|
| 31.
|
Soldatov, N. M.,
Bouron, A.,
and Reuter, H.
(1995)
J. Biol. Chem.
270,
10540-10543[Abstract/Free Full Text]
|
| 32.
|
Sharon, D.,
Vorobiov, D.,
and Dascal, N.
(1997)
J. Gen. Physiol.
109,
477-490[Abstract/Free Full Text]
|
| 33.
|
Wang, X. T.,
Nagaba, Y.,
Cross, H. S.,
Wrba, F.,
Zhang, L.,
and Guggino, S. E.
(2000)
Am. J. Pathol.
157,
1549-1562[Abstract/Free Full Text]
|
| 34.
|
Perez Reyes, E.,
Castellano, A.,
Kim, H. S.,
Bertrand, P.,
Baggstrom, E.,
Lacerda, A. E.,
Wei, X. Y.,
and Birnbaumer, L.
(1992)
J. Biol. Chem.
267,
1792-1797[Abstract/Free Full Text]
|
| 35.
|
McHugh, D.,
Sharp, E. M.,
Scheuer, T.,
and Catterall, W. A.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
12334-12338[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Dai, D. D. Hall, and J. W. Hell
Supramolecular Assemblies and Localized Regulation of Voltage-Gated Ion Channels
Physiol Rev,
April 1, 2009;
89(2):
411 - 452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Liu, M.-m. Wu, and H. H. Zakon
A Novel Na+ Channel Splice Form Contributes to the Regulation of an Androgen-Dependent Social Signal
J. Neurosci.,
September 10, 2008;
28(37):
9173 - 9182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kanevsky and N. Dascal
Regulation of Maximal Open Probability Is a Separable Function of Cav{beta} Subunit in L-type Ca2+ Channel, Dependent on NH2 Terminus of {alpha}1C (Cav1.2{alpha})
J. Gen. Physiol.,
June 26, 2006;
128(1):
15 - 36.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhou, K. Yu, K. L. McCoy, and A. Lee
Molecular Mechanism for Divergent Regulation of Cav1.2 Ca2+ Channels by Calmodulin and Ca2+-binding Protein-1
J. Biol. Chem.,
August 19, 2005;
280(33):
29612 - 29619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. I. Akbarali
Signal-Transduction Pathways that Regulate Smooth Muscle Function II. Receptor-ion channel coupling mechanisms in gastrointestinal smooth muscle
Am J Physiol Gastrointest Liver Physiol,
April 1, 2005;
288(4):
G598 - G602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yang, G. Liu, S. I. Zakharov, J. P. Morrow, V. O. Rybin, S. F. Steinberg, and S. O. Marx
Ser1928 Is a Common Site for Cav1.2 Phosphorylation by Protein Kinase C Isoforms
J. Biol. Chem.,
January 7, 2005;
280(1):
207 - 214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A.G. van der Heyden, T. J.M. Wijnhoven, and T. Opthof
Molecular aspects of adrenergic modulation of cardiac L-type Ca2+ channels
Cardiovasc Res,
January 1, 2005;
65(1):
28 - 39.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Z. Tang, M. C. Liang, S. Lu, D. Yu, C. Y. Yu, D. T. Yue, and T. W. Soong
Transcript Scanning Reveals Novel and Extensive Splice Variations in Human L-type Voltage-gated Calcium Channel, Cav1.2 {alpha}1 Subunit
J. Biol. Chem.,
October 22, 2004;
279(43):
44335 - 44343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Weiss, T. Doan, K. E. Bernstein, and N. Dascal
Modulation of Cardiac Ca2+ Channel by Gq-activating Neurotransmitters Reconstituted in Xenopus Oocytes
J. Biol. Chem.,
March 26, 2004;
279(13):
12503 - 12510.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|